Welcome to the forefront of conversational AI as we explore the fascinating world of AI chatbots in our dedicated blog series. Discover the latest advancements, applications, and strategies that propel the evolution of chatbot technology. From enhancing customer interactions to streamlining business processes, these articles delve into the innovative ways artificial intelligence is shaping the landscape of automated conversational agents. Whether you’re a business owner, developer, or simply intrigued by the future of interactive technology, join us on this journey to unravel the transformative power and endless possibilities of AI chatbots.
Upcoming Event
Mental Health
Reuters Connect//May 12, 2026//
OpenAI faces lawsuit in California court claiming chatbot gave advice that led to fatal overdose
The logo of OpenAI is displayed near a response by its AI chatbot ChatGPT on its website, in this illustration picture taken February 9, 2023. (REUTERS/Florence Lo/Illustration)
Reuters Connect//May 12, 2026//
The parents of a man who died of an accidental drug overdose last year sued OpenAI and its founder and CEO Sam Altman in a California court on Tuesday, alleging the man was coached to take a dangerous combination of substances by ChatGPT.
Leila Turner-Scott and Angus Scott say their son, Sam Nelson, 19, was using a chatbot for guidance on combining different drugs. They say it encouraged him to take the prescription drug Xanax to treat nausea caused by kratom, an herbal product with opioid-like effects.
The combination of those drugs and alcohol resulted in Nelson’s death in May 2025, according to the lawsuit, which was filed in state court in San Francisco.
The lawsuit seeks monetary damages and asks the court to pause OpenAI’s rollout of ChatGPT Health, a platform the company announced in January that allows users to upload medical records and receive personalized health advice.
Currently, ChatGPT users can join a waitlist to access ChatGPT Health. A report from OpenAI released in January showed that overall, 40 million users ask ChatGPT healthcare-related questions daily.
Drew Pusateri, a spokesperson for OpenAI, called the situation heartbreaking, and said the interactions took place on an earlier version of ChatGPT that is no longer available. The company is continuously working to improve ChatGPT’s safety, he said.
“ChatGPT is not a substitute for medical or mental health care, and we have continued to strengthen how it responds in sensitive and acute situations with input from mental health experts,” Pusateri said. “The safeguards in ChatGPT today are designed to identify distress, safely handle harmful requests, and guide users to real-world help.”
The lawsuit is the latest wrongful death action to be brought against an AI company and comes a little more than a day after the family of a man killed in a mass shooting at Florida State University sued OpenAI alleging that ChatGPT helped the shooter plan the attack.
Growing wave of AI lawsuits
Generative AI companies are facing a growing number of lawsuits accusing them of failing to prevent chatbot interactions that plaintiffs say contribute to self-harm, mental illness and violence.
The lawsuit filed by Nelson’s parents claims he was initially rebuffed by ChatGPT when he asked for advice on drug use, with the chatbot saying it could not assist and warning about the risks. But in 2024 the company launched ChatGPT-4o, which began giving Nelson information about drug interactions and dosing in authoritative language that mimicked a doctor, the lawsuit said.
Chatbot’s evolving responses
The chatbot told Nelson how to source illicit substances, advised him on which drug to take next and made suggestions based on the experiences Nelson said he was looking for, according to the lawsuit. The chatbot saved details about Nelson’s substance use in its memory, allowing it to offer more personalized recommendations, according to the filing.
The lawsuit accuses OpenAI of rushing out ChatGPT-4o to keep up with competitors like Alphabet’s Google, skipping needed safety testing. It accuses the company of designing a flawed product and failing to warn users of its risks, and cites a California law that bars AI companies from claiming a chatbot autonomously caused harm to a person as a defense.
“In California, if plaintiffs prove they were harmed by defendants’ AI-powered product, defendants will be liable for that harm, no matter how clever, independent, willful, spiteful, uncontrolled, rebellious, free-spirited, libertine, stochastic, or autonomous the beast they have birthed may be,” the lawsuit said.
(Reporting for Reuters by Diana Novak Jones in Chicago; Editing by Alexia Garamfalvi and Matthew Lewis.)
Share this!
A judge dismissed the indictment against Maryland resident Kilmar Abrego Garcia, citing retaliatory prosecutio […]
May 22, 2026
Trump's $1.776 billion anti-weaponization fund sparks outrage and legal challenges amid questions about tax im […]
May 22, 2026
Two Maryland doctors accused of sharing private health information with the intention of benefiting Russia are […]
May 22, 2026
The Justice Department added 77 permanent and 5 temporary immigration judges, the largest class ever, to reduc […]
May 22, 2026
A Maryland federal judge upheld punitive damages against the former Cecil County attorney in a First Amendment […]
May 21, 2026
Former DOJ attorney charged with stealing unreleased volume of Special Counsel Jack Smith's report on Trump cl […]
May 21, 2026
Sign up for your daily digest of Maryland news.
2 MD doctors who beat Russian conspiracy case sue over news release
22/5/2026
Moore to allow immigration bill to go into effect without signing
22/5/2026
Cecil County violated man’s 1st Amendment rights; judge upholds punitive d[…]
21/5/2026
26K-plus Marylanders could see insurance hikes under UnitedHealthcare
21/5/2026
4th Circuit blocks MD law on energy companies’ use of eco-friendly terms
21/5/2026
Commentary: Baltimore sheriff Sam Cogen reflects on jury duty and expresses concerns about federal l[…]
Commentary: Baltimore’s inspector general needs to be allowed to do her job of investigating city sp[…]
Commentary: Martin Wiley Littleton was a renowned New York trial lawyer famous for defending Henry K[…]
Commentary: Data centers in Maryland can help lower electricity costs by funding grid modernization […]
Commentary: Maryland attempts to target rent pricing algorithms, but this may worsen the housing sho[…]
Commentary: Maryland must decide whether to invest $85 million to buy the Preakness intellectual pro[…]
Commentary: Maryland’s attempt to stop companies from using personal data for undisclosed price disc[…]
Analysis: Trump ‘weaponization’ fund sparks outrage, but court chall[…]
22/5/2026
Trump administration brings on record new class of immigration judges
22/5/2026
Trump officials tried to ban half of US voting machines, citing conspiracy theor[…]
22/5/2026
Republican revolt over Trump ‘anti-weaponization’ fund stalls ICE fu[…]
22/5/2026
Former DOJ lawyer charged with theft of unreleased report on Trump documents cas[…]
21/5/2026
Submit an entry for the business calendar
The Daily Record is a digital-first daily news media company focused on law, government, business, recognition events, Power Lists, special products, public notices and more.
Get our free e-alerts & breaking news notifications!
Subscribe for access to the latest digital and special editions.
Click here for information about plaques, permissions and reprints of previous editions.
© 2026 BridgeTower Media. All rights reserved.
Use of this website is subject to its Terms of Use | Privacy Policy | Your California Privacy Rights/Privacy Policy | Do Not Sell My Info/Cookie Policy
This website uses cookies, web beacons, pixels, tags, software development kits, and related tracking technologies, as described in our Privacy Policy and Cookie Policy, for purposes that may include website operation, analytics, analyzing site usage, enhancing site navigation optimizing a user’s experience, and third-party advertising or marketing purposes. Through these technologies, we and certain third parties may automatically collect information about your interactions with our website, such as your browsing behavior and page views. We also may share this information about your activity on our website with our social media, advertising, analytics, and other business partners. By clicking “Accept All”, you consent to the use of these technologies and that we can share information about your activity on our website with third parties in accordance with our Privacy Policy and Cookie Policy. If you do not agree with our use of non-essential tracking technologies, please click “Reject All.” You may opt out of certain non-essential technologies by clicking “Cookie Settings.”